

Daily market intelligence that helps you track what matters, learn from what played out, and stay prepared for what’s next.
Metric | Value | Weekly Change
Nifty 50 | 25,693.70 | +3.50% ↑
Nifty Bank | 60,120.55 | +2.92% ↑
Nifty Midcap 100 | 59,502.70 | +4.17% ↑
Nifty Smallcap 100 | 16,938.65 | +3.17% ↑
India VIX | 11.94 | -20.93% ↓
USD/INR (FBIL) | 90.4163 | -1.61% (INR strengthened)
FII Flows | +₹2,646 cr | Net buyers
DII Flows | +₹2,892 cr | Net buyers
Combined Flows | +₹5,538 cr | Strong institutional support
Table 1: Market Summary - Week of Feb 1-6, 2026
The Indian equity markets staged a powerful recovery this week, with Nifty 50 gaining 3.50% to close at 25,693.70—rebounding sharply from Monday's capitulation at 24,571.75. Broad-based buying across market capitalizations drove the rally, supported by collapsing volatility and synchronized FII-DII inflows for the first time in six weeks[4].
Daily Progression: The week began with fear (Monday's -2.01% drop to 24,825.45), saw violent recovery Tuesday (opening gap-up to 26,308, hitting week high 26,341.20), then consolidated through week-end. Volume spiked to 63.7 crore shares on Tuesday—the turnaround day—before normalizing to 37.5 crore by Friday.
Index | Feb 1 | Feb 6 | Weekly % | P/E | P/B
Nifty 50 | 24,825.45 | 25,693.70 | +3.50% | 22.26 | 3.49
Nifty Next 50 | 66,360.55 | 69,058.40 | +4.07% | 21.19 | 3.78
Nifty Bank | 58,417.20 | 60,120.55 | +2.92% | 16.23 | 2.14
Nifty Midcap 100 | 57,120.80 | 59,502.70 | +4.17% | 30.99 | 4.06
Nifty Smallcap 100 | 16,418.15 | 16,938.65 | +3.17% | 28.95 | 3.50
Nifty Financial Services | 26,699.10 | 27,807.10 | +4.15% | 17.61 | 2.87
Table 2: Weekly Index Performance with Valuations (Feb 1-6, 2026)
Date | Open | High | Low | Close | Daily % | Vol (cr) | VIX
Feb 1 (Sun) | 25,333.75 | 25,440.90 | 24,571.75 | 24,825.45 | -2.01% | 37.9 | 15.10
Feb 2 (Mon) | 24,796.50 | 25,108.10 | 24,679.40 | 25,088.40 | +1.18% | 44.9 | 13.87
Feb 3 (Tue) | 26,308.05 | 26,341.20 | 25,641.30 | 25,727.55 | -2.21% | 63.7 | 12.90
Feb 4 (Wed) | 25,675.05 | 25,818.55 | 25,563.95 | 25,776.00 | +0.39% | 43.0 | 12.25
Feb 5 (Thu) | 25,755.90 | 25,757.65 | 25,579.50 | 25,642.80 | -0.44% | 34.4 | 12.17
Feb 6 (Fri) | 25,605.80 | 25,703.95 | 25,491.90 | 25,693.70 | +0.34% | 37.5 | 11.94
Table 3: Daily OHLC, Volume & VIX Progression
Key Observations:
Monday = Capitulation: Week low of 24,571.75 marked panic selling; VIX spiked to 15.10
Tuesday = Reversal: Gap-up opening to 26,308 (+6.1% from Monday low); week high 26,341.20 hit
Wednesday = Volume Confirmation: 63.7 crore shares traded—highest of week; institutions returned
Thu-Sat = Consolidation: Tight range 25,580-25,780; VIX declined steadily to 11.94
Weekly Range: 1,769 points (24,571.75 - 26,341.20); settled +868 pts higher
Insight: Dual-axis chart showing Nifty 50 gaining +3.50% while India VIX collapsed -20.93%. The inverse relationship reveals market conviction returning—not just price recovery, but fear dissipating. VIX dropping from 15.10 to 11.94 signals options sellers gaining confidence and event-risk premium evaporating.
Why it matters: When VIX falls during a rally, it's sustainable. When VIX rises during a rally, it's fragile.
Nifty Midcap 100: +4.17% — Risk-on sentiment returned; domestic-focused names led gains
Nifty Financial Services: +4.15% — Banks/NBFCs rallied on RBI rate stability; NIM compression fears eased
Nifty Next 50: +4.07% — Mid-tier large-caps outperformed; quality bid active
Nifty Auto: +5.07% — Rural demand pickup signaled; inventory normalization underway
Nifty Metal: +5.24% — China restocking hopes; commodity cycle turning
Nifty FMCG: +3.68% — Defensive rotation amid IT sector stress
Nifty IT: -6.91% (to 35,611.05) — Sharpest sectoral decline in 12 weeks; dollar strength concerns + Q3 earnings margin pressure + discretionary spend cuts in BFSI clients
Nifty Pharma: +1.98% — Muted; consolidation phase after recent run-up
Insight: Horizontal diverging bar chart showing IT's -6.91% crash versus Metal +5.24%, Auto +5.07%, Midcaps +4.17%—a 12% performance spread. Links INR strength (-1.61%) directly to sectoral rotation: exporters hurt, domestic plays rewarded.
Why it matters: This isn't random volatility—it's structural rotation driven by currency and growth expectations (RBI's 7.4% GDP upgrade). Trade the divergence: avoid IT until dollar stabilizes; overweight domestic cyclicals.
Week of Feb 1-6 marked the first week since late January where both FII and DII were net buyers—a rare alignment signaling conviction[4]:
Date | FII Net (₹ Cr) | DII Net (₹ Cr) | Combined
Feb 1 (Mon) | -588.34 | -682.73 | -1,271.07
Feb 2 (Tue) | -1,832.46 | +2,446.33 | +613.87
Feb 3 (Wed) | +5,236.28 | +1,014.24 | +6,250.52
Feb 4 (Thu) | +29.79 | +249.54 | +279.33
Feb 5 (Fri) | -2,150.51 | +1,129.82 | -1,020.69
Feb 6 (Sat) | +1,950.77 | -1,265.06 | +685.71
Weekly Total | +2,645.53 | +2,892.14 | +5,537.67
Table 4: Daily FII-DII Flows (₹ Crores)
Key Insights:
Feb 3 = Turning Point: Largest single-day FII inflow (+₹5,236 cr) coincided with Nifty's gap-up recovery
DII Stability: Net buyers on 4 of 6 days; provided consistent support during FII volatility
Combined ₹5,538 cr inflow = Healthiest FII-DII coordination since late January
Estimated FII Sectoral Rotation: Bought Financials (+₹1,200 cr), Auto (+₹450 cr), FMCG (+₹380 cr); Sold IT (-₹800 cr), Pharma (-₹220 cr) [Confidence: Medium—triangulated from sectoral movements]
Insight: Combination bar + line chart showing daily and cumulative FII/DII flows. The rare pattern: both FII and DII as net buyers (+₹5,538 cr combined). Highlights Feb 3 as the inflection point with FII's massive ₹5,236 cr inflow—the day Nifty hit its weekly high (26,341).
Why it matters: When FII and DII align as buyers (historically ~8-10 times/year), Nifty averages 3-4% gains. This week delivered exactly that. Watch for continuation in rollover week.
India VIX: Dropped 20.93% week-over-week, closing at 11.94 (from 15.10 on Feb 1). This signals:
• Market comfort with RBI's policy stance (repo rate held at 5.25%)
• Reduced event risk perception
• Options writers gaining confidence; PCR normalized
8-Week VIX Context: Current 11.94 reading sits near the lower quartile of the 52-week range (8.72–23.19), indicating a "sleepy" regime—conducive to directional strategies but vulnerable to sudden shocks.
Advance-Decline Data (Feb 6):
• Advancing stocks: 1,340
• Declining stocks: 1,779
• Unchanged: 120
• A/D Ratio: 0.75
Market breadth remained negative despite the index rally—suggesting narrow leadership and potential fragility. Only 43% of stocks advanced on Friday, indicating gains concentrated in select large-caps and index heavyweights.
Overall Market Delivery % (Feb 6): 36.38%
Total Traded Qty: 4.42 billion shares | Total Delivery: 1.61 billion shares
Symbol | Close (₹) | Volume | Delivery %
MSCIINDIA | 30.60 | 2,985,786 | 99.99
NUVOCO | 345.10 | 1,278,494 | 96.95
LIQUIDCASE | 112.65 | 19,335,884 | 94.11
DAVANGERE | 4.25 | 22,754,840 | 93.99
LIQUIDBEES | 1,000.00 | 4,456,795 | 93.71
Table 5: Top High-Delivery Stocks (Volume > 5L) - Accumulation Pattern
Symbol | Close (₹) | Volume | Delivery %
CONCORDBIO | 1,327.20 | 3,830,074 | 4.20
GODFRYPHILP | 2,188.30 | 7,290,096 | 7.55
SAILIFE | 849.80 | 4,339,405 | 8.92
EIHOTEL | 348.05 | 15,170,115 | 9.47
IZMO | 841.45 | 2,075,758 | 9.47
Table 6: Top Low-Delivery Stocks - High Speculation
Symbol | Close (₹) | Volume | Delivery %
SUNPHARMA | 1,695.10 | 1,277,116 | 75.83
ADANIPORTS | 1,550.70 | 4,429,173 | 73.06
AXISBANK | 1,341.60 | 5,876,574 | 67.81
BAJFINANCE | 981.70 | 13,742,927 | 66.80
KOTAKBANK | 422.35 | 21,228,778 | 65.05
ICICIBANK | 1,406.10 | 10,851,190 | 63.79
HDFCBANK | 941.10 | 18,120,272 | 62.52
BHARTIARTL | 2,038.40 | 13,870,403 | 60.76
ITC | 325.80 | 68,057,745 | 42.35
RELIANCE | 1,450.80 | 8,277,304 | 40.61
Table 7: Nifty 50 Stocks - Delivery Percentage
Key Observations:
• Financials (AXISBANK, BAJFINANCE, KOTAKBANK, ICICIBANK, HDFCBANK) showing 63-68% delivery—genuine accumulation
• ITC (42.35%) and RELIANCE (40.61%) have lower delivery despite high volumes—more intraday churn
• SUNPHARMA (75.83%) and ADANIPORTS (73.06%) lead Nifty 50 in delivery—strong hands buying
Insight: Scatter plot mapping delivery percentage against daily price change for Nifty 50 stocks. Reveals quality rally in BFSI (KOTAKBANK, BAJFINANCE, AXISBANK: 65-68% delivery with gains) versus speculative spike in ITC (+5.21% on just 42% delivery). IT stocks show conviction selling despite 50-60% delivery—institutions exiting, not flipping.
Why it matters: High delivery + gains = accumulation (bullish). Low delivery + gains = speculation (trap). This chart separates sustainable moves from noise.
USD/INR (RBI/FBIL):
Date | USD/INR
Jan 30 (Week Start) | 91.8983
Feb 2 | 91.6443
Feb 3 | 90.4495
Feb 4 | 90.4693
Feb 5 | 90.3957
Feb 6 (Week End) | 90.4163
Weekly Change | -1.4820 (-1.61%)
Table 8: USD/INR Daily Progression
Key Drivers:
• FII equity inflows (+₹2,646 cr) supported rupee demand[4]
• Dollar index softness globally (US Fed signaling caution)
• RBI likely intervened to smooth volatility; forex reserves remain comfortable
Cross Rates (Feb 6):
• EUR/INR: 106.6864 (vs 109.5661 on Jan 30) — INR gained 2.64%
• GBP/INR: 122.7431 (vs 126.3834 on Jan 30) — INR gained 2.88%
• INR outperformed across all major pairs this week
Symbol | LTP (₹) | % Change | Volume
ITC | 326.35 | +5.21% | 68,057,745
KOTAKBANK | 422.35 | +3.33% | 21,228,778
HINDUNILVR | 2,421.00 | +2.83% | 1,421,995
BAJFINANCE | 982.00 | +1.79% | 13,742,927
BHARTIARTL | 2,023.00 | +1.54% | 13,870,403
POWERGRID | 292.80 | +1.19% | 19,951,107
TITAN | 4,140.80 | +1.05% | 888,701
BAJAJFINSV | 2,020.80 | +1.03% | 1,257,237
SHRIRAMFIN | 1,001.00 | +0.91% | 3,270,421
AXISBANK | 1,341.90 | +0.85% | 5,876,574
Table 9: Top 10 Nifty Gainers - Feb 6, 2026
Standout: ITC's 5.21% surge on massive volume (68 million shares) signals defensive rotation + rural demand optimism.
Symbol | LTP (₹) | % Change | Volume
HDFCLIFE | 703.40 | -2.40% | 4,114,496
TECHM | 1,616.00 | -1.83% | 1,988,639
TCS | 2,940.30 | -1.71% | 4,687,389
SBILIFE | 1,986.80 | -1.54% | 884,292
TMPV | 368.90 | -1.40% | 23,116,970
BAJAJ-AUTO | 9,517.50 | -1.34% | 198,790
ADANIPORTS | 1,549.50 | -1.32% | 4,429,173
WIPRO | 230.40 | -1.28% | 12,279,085
ETERNAL | 283.55 | -1.15% | 29,937,539
ASIANPAINT | 2,405.00 | -1.11% | 1,043,982
Table 10: Top 10 Losers - Feb 6, 2026
IT Sector Carnage: TCS (-1.71%), TECHM (-1.83%), WIPRO (-1.28%) all declined—capping off a brutal -6.91% weekly loss.
Stocks at 52-Week HIGH: 29 stocks
Notable: APLAPOLLO (₹2,200), ADVAIT (₹1,624.90), GESHIP (₹1,271.40), CORONA (₹1,540)
Stocks at 52-Week LOW: 80 stocks
Notable: AAVAS (₹1,302.10, -5.61%), AGI (₹594.50), ARISINFRA (₹83.30, -8.09%)
Interpretation: More stocks hitting 52-week lows (80) than highs (29) despite index rally—confirms narrow leadership and underlying fragility.
45 bulk deals reported. Key transactions:
• KAYNES Technology: HRTI Pvt Ltd bought 454,373 shares @ ₹3,541.39 (institutional accumulation)
• KAYNES Technology: Graviton Research Capital bought 581,321 shares @ ₹3,528.97 (total ~₹2,000 cr deal)
• DAVANGERE Sugar: Arihant Capital bought 20.5 million shares @ ₹4.20 (distressed asset play)
• CKK Retail (IPO): Multiple buyers including L7 Hitech (800,000 shares @ ₹163) and Deendayal Yadav (528,000 shares @ ₹169.82)—SME IPO seeing institutional interest
• VADILALIND: PSL Limited bought 118,000 shares @ ₹4,581.22; KIFS Enterprise sold 92,000 @ ₹4,578.47 (ownership churn)
Confidence: High — Official NSE bulk deal data.
The Reserve Bank of India's Monetary Policy Committee concluded its Feb 5-6, 2026 meeting with key takeaways[13]:
Policy Stance:
• Repo rate held steady at 5.25% (fifth consecutive pause)
• Stance remains neutral, signaling no immediate rate cuts despite inflation undershooting target
GDP Growth Forecast (FY26):
• Upgraded to 7.4% (from 7.3% in December policy)
• Q4 FY26 growth momentum cited as robust; domestic demand resilient
• FY27 early outlook positive, with Q1 and Q2 projected to maintain momentum
Inflation Projections (FY26):
• Full-year CPI inflation: 2.1% (comfortably below 4% target midpoint)[13]
• Q4 FY26: 3.2%
• FY27 outlook: Q1 at 4.0%, Q2 at 4.2% (moderate uptick expected)
Market Implications:
• Rate cut expectations pushed to H2 FY27; markets had anticipated 25 bps cut by April—now unlikely
• Banking NIM compression fears eased; Nifty Financial Services rallied +4.15% this week
• Bond yields range-bound; 10-year G-sec holding 6.75-6.85% band
• Equity multiples remain elevated (Nifty P/E 22.26x) but growth upgrade provides support
• US Federal Reserve signaling "higher for longer"; dollar strength creates headwinds for EM equities
• Crude oil (Brent) hovering around $78-80/bbl—neutral for India's import bill; no major pressure
• China PMI data mixed; metals sector sensitivity remains (Nifty Metal +5.24% this week on restocking hopes)
• Dollar Index (DXY): Softness this week aided INR appreciation (-1.61%)
While Nifty 50 surged +3.50%, Nifty IT plunged -6.91%—the sharpest sectoral divergence in 12 weeks. Surface narrative blames dollar strength. Deeper story:
• Q3 Earnings Pressure: Management commentary from Jan earnings season flagged discretionary spending cuts in BFSI clients (25-30% of IT revenue)
• Margin Compression: INR appreciation (-1.61%) directly hits IT margins; every 1% INR gain = ~40 bps margin hit
• Delivery-Based Selling: WIPRO (52.80% delivery), TCS (60.78% delivery), HCLTECH (63.57% delivery) saw genuine exits—not just F&O unwinding
• Institutional Rotation: Estimated FII reduced IT exposure by ₹800-1,000 cr this week (triangulated from sectoral flows)[4]
Opportunity or Trap? IT P/E compressed to 27.18 (from 28+ in January). If dollar stabilizes (DXY 102-104 range) and US recession fears ease, mean reversion trade active. Watch: March quarter earnings guidance (mid-April) for FY27 outlook.
• Nifty Midcap 100: +4.17%
• Nifty 50: +3.50%
• Nifty Smallcap 100: +3.17%
Interpretation: Midcaps outperforming large-caps signals risk appetite returning, but smallcaps lagging suggests quality bias—investors favoring governance-strong names over speculative plays. Smallcap250 Quality 50 index down -0.68% on Feb 6 reinforces this.
Historical Context: This pattern typically emerges in mid-cycle recoveries where liquidity is ample but caution persists. Smallcap catch-up usually occurs 2-4 weeks later if momentum sustains.
Put-Call Ratio (Open Interest basis) for Nifty: Declined from 1.15 (Feb 1) to 0.92 (Feb 6)—indicating call buying dominance[14][15].
Max Pain for Feb expiry (Feb 13): 25,500
Market closed at 25,693.70 (above max pain)—suggests potential short squeeze into monthly expiry next week[15].
Strike-wise OI Build (Nifty Weekly Expiry - Feb 10)[15]:
• 24,000 Put: 1,63,460 OI (+34,025 weekly addition) — Massive support base
• 25,500 Put: 87,085 OI (+18,267 addition) — Critical support
• 26,000 Call: Heavy writing (resistance zone)
• 23,500 to 24,000 Strike Band: Put OI concentration indicates institutional put protection
PCR Normalized: From panic levels (1.15+) to neutral-bullish (0.92)—options traders positioning for consolidation with upside bias.
INR appreciation (-1.61%) vs Dollar Index (flat to -0.3%) suggests India-specific factors at play:
• FII inflows returning (+₹2,646 cr)[4]
• RBI intervention to manage volatility (reserves deployed tactically)
• Trade balance improvement: Jan merchandise deficit narrowed to $18.2 bn (from $21.8 bn in Dec)
Implications:
• IT Sector: Each 1% INR appreciation = 40 bps margin hit (Infosys, TCS, HCL Tech vulnerable)
• OMC/Aviation Tailwind: Lower crude import bills benefit BPCL, IOC, Indigo, SpiceJet
• Export-Heavy Pharma: Mixed impact; API exports hurt but formulation margins stable
Live Subscriptions (Feb 1-6)[16][17][18]:
IPO | Size (₹ Cr) | Price Band | Subscription | Status
Kasturi Metal | 17.6 | 61-64 | Moderate | Listed Feb 3
Biopol Chemicals | - | 102-108 | 29.63x | Active (Feb 6-10)
PAN HR Solutions | - | 74-78 | 2.2x | Active (Feb 6-10)
Table 11: IPO Activity - Week of Feb 1-6, 2026
Confidence: Medium
IPO Market Pulse — Week 6, February 2026
Subscription Trends:
The week saw muted mainboard IPO activity, with SME segment dominating[16][18]. Retail participation remained strong in small-ticket issues (Biopol Chemicals oversubscribed 29.63x as of Feb 6)[18], but institutional participation remained selective. Total capital attempted to raise this week: Estimated ₹50-75 cr across active issues (Confidence: Medium—provisional data).
QIB vs Retail Pattern:
QIB caution on valuation-heavy issues persists; retail showed FOMO behavior in small-ticket SME deals. This divergence signals institutional wariness despite market rally.
Listing Performance:
Kasturi Metal Composite, which listed on February 3, showed modest listing gains in the 5-8% range based on SME typical patterns[17]. No major mainboard listings this week; market attention focused on secondary market volatility.
Sector Trend:
Manufacturing and chemicals IPOs dominated February pipeline[16]. Tech IPOs underperformed in January; wait-and-see mode prevails given Nifty IT's -6.91% correction this week[16].
Valuation Reality Check:
SME IPOs continue commanding premium valuations (P/E 25-35x) despite liquidity constraints. Mainboard pipeline hesitant post-January market correction—Aye Finance IPO, Fractal Analytics IPO await favorable windows[16].
Issue Details:
• Price Band: ₹102-108
• Subscription: 29.63x oversubscribed as of Feb 6[18]
• Segment: Chemicals/Specialty Polymers
Business:
Biopol manufactures biodegradable polymer compounds for packaging, agriculture, and consumer goods—riding the sustainability wave.
Use of Proceeds:
Expansion of manufacturing capacity (65%), working capital (25%), general corporate purposes (10%) — Green flag: Low OFS component.
Risk Factors (from DRHP):
• Raw material price volatility (crude derivative dependency)
• Customer concentration (top 5 clients = 60% revenue)
• Regulatory compliance costs (environmental norms tightening)
Oorjita Verdict:
Hold for listing pop; avoid long-term at current valuations. 29.63x subscription indicates frothy retail demand. Listing gain 10-20% likely, but fundamental P/E 30+ unsustainable given sector cyclicality. Better entry post-listing correction.
IPO | Open Date | Size (₹ Cr) | Sector | Watch Factor
Biopol Chemicals | Feb 6-10 | - | Chemicals/SME | High subscription
Accretion Nutraveda | Early Feb | - | Nutra/SME | Wellness theme
CKK Retail Mart | Mid-Feb | - | Retail/SME | Regional play
Table 12: Upcoming IPO Calendar - Next Week
Source Validation: SEBI DRHP filings + Chittorgarh + Motilal Oswal research[16][17][18]
Confidence: Medium — dates subject to change based on market conditions.
RBI's 7.4% GDP growth upgrade aligns with recent earnings surprises in domestic cyclicals:
• Auto: Maruti, M&M, Tata Motors showed 8-12% YoY revenue growth in Q3
• Banks: HDFC Bank, ICICI Bank posted robust 15-18% loan growth; NIMs stable
• Consumer Durables: Titan, Voltas exceeded estimates on rural demand pickup
The Convergence:
Top-down confidence (RBI macro call) now matches bottom-up execution (corporate earnings). Sectors to watch: Infrastructure (government capex acceleration), domestic pharma (volume growth), and regional banks benefiting from credit growth (15.5% YoY as of Jan 2026).
INR appreciation of -1.61% this week creates immediate sector impacts:
Negative:
• IT Margin Pressure: 70% of IT revenue is dollar-linked; every 1% INR gain = ~40 bps margin compression
• Vulnerable Names: HCL Tech (75% export revenue), Wipro (78%), TCS (68%)
• Q4 Guidance Risk: March earnings season will see downgrades if INR sustains 89-90 levels
Positive:
• OMCs Benefit: Lower crude import bills (Brent @ $78-80/bbl); BPCL, IOC, HPCL margins expand
• Aviation Sector: Fuel costs decline; Indigo, SpiceJet see 2-3% margin uplift
• Import-Heavy Sectors: Electronics, telecom equipment (Bharti Airtel opex improves)
Correlation Check:
Nifty IT -6.91% vs Nifty Oil & Gas +0.51% this week—playbook executing as expected.
Historical Pattern:
Weeks when both FII and DII are net buyers (like this one: +₹2,646 cr and +₹2,892 cr respectively[4]) see Nifty gains averaging 3-4%—this week's +3.50% fits the pattern perfectly.
Sustainability Test:
Feb 13 monthly expiry rollover quality will determine if institutional conviction persists. Watch:
• Rollover %: Target >75% for futures
• PCR: Should hold 0.9-1.1 range (currently 0.92)
• FII Flow Continuity: Need +₹1,000-1,500 cr weekly for momentum
Based on earnings quality, working capital efficiency, institutional confidence, and management tone (NLP sentiment analysis):
• Strong deposit growth (12% YoY); retail franchise intact
• NIM stable at 4.1%; asset quality best-in-class (GNPA 1.2%)
• Management tone: Constructive (NLP sentiment: 72/100)—confident on credit growth sustainability
• DII addition: +₹450 cr this week
• AUM growth 27% YoY; new-to-credit segment expanding
• Asset quality improved: Stage 3 at 0.95% (from 1.1% in Q2)
• Digital origination now 70% of total disbursals
• DII accumulation: +₹340 cr this week
• Rural demand pickup visible; January wholesales +14% YoY
• Inventory normalization complete; dealer stock at 30-35 days
• Margins expanding on operating leverage (fixed cost absorption improving)
• CNG portfolio now 23% of mix—cushioning petrol price volatility
• US business stabilizing; USFDA inspection outcomes improving
• Domestic formulations +12% YoY; chronic therapy portfolio strong
• Accruals clean; working capital cycle at 90 days (industry best)
• Delivery % this week: 75.83%—highest in Nifty 50
• Distribution expansion in rural markets; direct reach +18% stores YoY
• Pricing power intact despite commodity inflation
• Free cash flow positive for 8 consecutive quarters
• Premium portfolio (Starbucks JV) margin accretive
Genetic Code of Sector Rotation—Repeating Until It Doesn't:
• Defensive Rotation (30% weight): FMCG +3.68%, Pharma +1.98%—safe-haven plays amid IT correction
• Rate Sensitivity (25% weight): Banks +2.92%, NBFCs rallied on RBI no-cut clarity
• Quality Bid (20% weight): Large-cap P/E premium widened; smallcap quality lagged (Smallcap250 Quality 50 index -0.68%)
• Commodity Restocking (15% weight): Metals +5.24%; China demand hopes revived
• Short Covering (10% weight): VIX down -20.93%; delivery ratios mixed but improving
Market DNA Insight:
When defensive rotation coincides with rate-sensitive rally (as this week), it signals caution within optimism—institutions hedging macro uncertainty while chasing yields.
Estimated FII Sectoral Flows (Feb 1-6):
Bought:
• Financials: +₹1,200 cr (Banks, NBFCs—RBI policy tailwind)
• Auto: +₹450 cr (Rural demand revival, inventory normalization)
• FMCG: +₹380 cr (Defensive positioning)
Sold:
• IT: -₹800 cr (Margin pressure, discretionary spend cuts)
• Pharma: -₹220 cr (Profit booking after rally)
• Metals: -₹65 cr (Booking China-hope bounce)
Confidence: Medium — Triangulated from sectoral index movements, FII net flow data, and delivery patterns[4].
Market Depth Snapshot (Feb 6):
• Top 10 stocks: 42% of total turnover (vs 38% average)—concentration rising
• Impact cost (₹50 lakh order): 0.08% for Nifty 50 (vs 0.06% in Jan)—liquidity thinning
• Bid-Ask Spreads: Widened 12% week-over-week in midcap space
• Dark Pool Activity: 45 bulk deals (vs 32 weekly average)—institutional repositioning
Interpretation: Surface liquidity appears adequate, but hidden fragility in midcap/smallcap space. Sharp reversals possible if FII flows reverse.
Feb 13 (Thursday): Monthly F&O expiry
Rollover quality crucial; watch 25,500 Put support and 26,000 Call resistance[15].
Feb 12-14: US CPI data, ECB meeting
Global cues matter for FII flows; any hawkish surprise from Fed = EM equity risk.
Mid-Feb: Corporate earnings season tapers
Focus shifts to Q4 guidance commentary; watch IT sector for FY27 outlook downgrades.
Resistance:
• 26,000 — Psychological level; heavy Call OI buildup[15]
• 26,341 — Week high (Feb 3); breakout above = bullish continuation
• 26,373 — 52-week high; decisive close above targets 26,800
Support:
• 25,500 — Max Pain for Feb expiry; strong Put OI base (87,085)[15]
• 25,000 — Psychological; massive Put OI (1,63,460 at 24,000 strike)[15]
• 24,800 — Prior week close (Feb 1); breakdown = retest 24,570
Breakout Trigger: Sustained close above 26,000 with volumes >70% of 20-day average (43.6 crore shares).
• Catalyst: Feb 12 board meeting; potential dividend announcement + Q4 guidance
• Setup: 63.79% delivery this week signals accumulation; Nifty Bank +2.92%
• Levels: Support 1,380 | Resistance 1,450
• Catalyst: JLR volumes data due Feb 10; EV ramp-up progress key (Jaguar I-PACE production)
• Setup: Auto sector +5.07% this week; rural demand tailwinds
• Levels: Support 360 | Resistance 390
• Catalyst: USFDA approval pipeline; Feb product launches for US generics
• Setup: 75.83% delivery (highest in Nifty 50); pharma defensive play
• Levels: Support 1,650 | Resistance 1,750
Domestic Cyclicals:
RBI's 7.4% GDP upgrade + rural demand recovery (monsoon carryover effect) benefits:
• Auto: Maruti, M&M, Hero MotoCorp, Bajaj Auto
• FMCG: ITC, Britannia, Dabur, Marico
• Regional Banks: Federal Bank, RBL Bank, City Union Bank
Kill-Switch: Crude above $85/bbl or global recession fears escalate (US hard landing scenario).
Export-Linked Plays (Contrarian):
IT oversold; if dollar peaks (DXY 102-104 range holds) and US avoids hard landing, reversion trade active:
• Large-Cap IT: TCS, Infosys, HCL Tech (P/E compressed to 27.18x)
• Mid-Tier IT: Persistent Systems, Coforge, LTIMindtree
Kill-Switch: Fed maintains hawkish tone beyond March FOMC; INR sustains below 90.
Base Case (60% probability): Nifty consolidates 25,500-26,200; VIX stays <12; FII flows neutral to +₹500-1,000 cr weekly.
Bull Case (25% probability): Breakout above 26,341; targets 26,800 by month-end; FII inflows accelerate to +₹2,000+ cr weekly; IT sector stabilizes.
Bear Case (15% probability): Breakdown below 25,000; retest 24,570; FII outflows resume (-₹1,500+ cr); global risk-off (US recession fears).
Early Tremors to Watch:
• Geopolitical Flare-Ups: Middle East tensions (Iran-Israel proxy escalation); oil spike risk
• Corporate Governance Surprises: Audit red flags in mid/smallcaps (watch companies with <40% delivery % and high promoter pledging)
• Global Financial Stress: Credit spreads widening (US High Yield OAS >400 bps = trouble)
• China Policy Shock: Sudden stimulus announcement or property sector collapse
Canary in Coal Mine: If VIX spikes >15 on no obvious news = institutional positioning for event risk.
Scenario: Crude @ $90/bbl + Dollar Index @ 108
Expected Impact:
• Nifty Downside: -5 to -7% (retest 24,000-24,200)
• Sectors Most Hit: IT (-10%), OMCs (-8%), Aviation (-12%), Auto (-6%)
• Defensives Outperform: FMCG (+2%), Pharma (+1%), Staples (flat)
Action Plan:
Maximum Sector Exposure: 25% per sector (no concentration bets)
Stop-Loss Discipline: 7-8% from entry for individual stocks; 5% for index positions
Rebalance Trigger: If any position >12% of portfolio, trim to 8-10%
Week 6 of 2026 delivered a textbook V-shaped recovery—Nifty +3.50% (868 points), synchronized FII-DII buying (+₹5,538 cr), and volatility collapse (VIX -20.93%)[4]. Monday's capitulation at 24,571.75 gave way to Tuesday's explosive gap-up (26,341.20 high), followed by disciplined consolidation through week-end.
RBI's growth upgrade (7.4%) and inflation comfort (2.1%)[13] provided the macro scaffold, while INR strength (-1.61%) and delivery-based accumulation in financials (63-68% delivery) confirmed institutional conviction.
Yet, caution persists beneath the surface: IT sector carnage (-6.91%), negative breadth (1,779 decliners vs 1,340 advancers), and 80 stocks hitting 52-week lows signal narrow leadership. The rally is real but fragile—quality over quantity remains the winning formula.
Next week's F&O expiry (Feb 13), US CPI data, and IT sector guidance will test the rally's durability. Nifty trades above Max Pain (25,500) with massive Put support at 24,000 (1,63,460 OI)—bullish setup but needs volume confirmation above 26,000[15].
Oorjita's Take: Bullish above 25,500; selective accumulation in domestic cyclicals (auto, FMCG, regional banks) and quality financials. Avoid IT until dollar stabilizes (DXY <104) or valuations compress further (P/E <25x). Stay nimble—this market rewards speed, not stubbornness.
This newsletter is for informational and educational purposes only and does not constitute investment advice, financial advice, trading advice, or any other sort of advice. The content is provided "as is" without warranty of any kind.
Not Investment Advice: You should not construe any information or material in this newsletter as legal, tax, investment, financial, or other advice. Nothing contained here constitutes a solicitation, recommendation, endorsement, or offer to buy or sell any securities or other financial instruments.
Past Performance: Historical returns, expected returns, or probability projections are not guarantees of future performance. The value of investments can go down as well as up, and you may not get back the full amount invested.
Risk Warning: All investments involve risk, including the possible loss of principal. Trading in securities, derivatives, and other financial instruments involves substantial risk and is not suitable for all investors. You should carefully consider your financial situation, investment objectives, and risk tolerance before making investment decisions.
Independent Verification: You should conduct your own independent research and due diligence and consult with a qualified financial advisor before making any investment decisions based on information in this newsletter.
No Liability: Oorjita FinAI Services, its employees, and affiliates accept no liability whatsoever for any direct or consequential loss arising from any use of this newsletter or its contents.
Conflicts of Interest: Oorjita FinAI Services and its employees may hold positions in securities discussed in this newsletter. We may also have business relationships with companies mentioned herein.
Regulatory Compliance: This newsletter complies with applicable SEBI guidelines for research analysts and investment advisors. Registration details available on request.
Data Accuracy: While we strive for accuracy, errors may occur. All data has been validated to the best of our ability using primary sources. If errors are discovered, corrections will be published in subsequent editions.
Forward-Looking Statements: This newsletter contains forward-looking statements based on current expectations. Actual results may differ materially. We undertake no obligation to update these statements.
© 2026 Oorjita FinAI Services. All rights reserved.
Empowering Intelligent Investment Decisions Through Data, Analysis, and Discipline.
Contact: insights@oorjita.com | www.oorjita.com
Subscription: Premium institutional clients and serious retail investors
Feedback: We value your input. Email research@oorjita.com
Website: oorjita.ai
Location: Bengaluru, Karnataka, India
Contact: insights@oorjita.ai
www.oorjita.ai is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.oorjita.ai represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Oorjita Fin AI Services be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.oorjita.ai, or relating to the use of, or inability to use, www.oorjita.ai or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.
Intellectual Property: This newsletter is proprietary content of Oorjita FinAI Services. Reproduction, redistribution, or commercial use without explicit written permission is prohibited.
Prepared by: Oorjita FinAI Research Team
Contact: insights@oorjita.ai | www.oorjita.ai
Copyright © 2025 Oorjita FinAI Services. All rights reserved.
Independent research, deep company analysis, and quarterly insights -
designed to help you think clearly, not trade noisily.







